Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
BMJ Open
|
November 25, 2017
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis
Paolo Eusebi, Oskar Hansson, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
Silvia Paciotti, Erik Stoops, Cindy François, et al.
Cancers
|
August 7, 2021
Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
Kelechi Njoku, Davide Chiasserini, Bethany Geary, et al.
Journal of Neuroimmunology
|
July 14, 2007
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients
Paola Sarchielli, Massimiliano Di Filippo, Antonio Candeliere, et al.
Neurobiology of Disease
|
November 17, 2023
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP
Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 2016
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
Tim Moors, Silvia Paciotti, Davide Chiasserini, et al.
Alzheimer'S Research & Therapy
|
May 22, 2025
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease
Lorenzo Gaetani, Giovanni Bellomo, Davide Chiasserini, et al.
Neurobiology of Disease
|
October 19, 2013
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence
Massimiliano Di Filippo, Alessandro Tozzi, Michela Tantucci, et al.
The Journal of Membrane Biology
|
June 13, 2015
Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis
Davide Chiasserini, Michela Mazzoni, Federico Bordi, et al.
Frontiers in Oncology
|
November 23, 2020
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
Kelechi Njoku, Davide Chiasserini, Eleanor R Jones, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
BMJ Open
|
November 25, 2017
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis
Paolo Eusebi, Oskar Hansson, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
May 6, 2021
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement
Silvia Paciotti, Erik Stoops, Cindy François, et al.
Cancers
|
August 7, 2021
Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
Kelechi Njoku, Davide Chiasserini, Bethany Geary, et al.
Journal of Neuroimmunology
|
July 14, 2007
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients
Paola Sarchielli, Massimiliano Di Filippo, Antonio Candeliere, et al.
Neurobiology of Disease
|
November 17, 2023
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP
Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 1, 2016
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links
Tim Moors, Silvia Paciotti, Davide Chiasserini, et al.
Alzheimer'S Research & Therapy
|
May 22, 2025
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease
Lorenzo Gaetani, Giovanni Bellomo, Davide Chiasserini, et al.
Neurobiology of Disease
|
October 19, 2013
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence
Massimiliano Di Filippo, Alessandro Tozzi, Michela Tantucci, et al.
The Journal of Membrane Biology
|
June 13, 2015
Identification and Partial Characterization of Two Populations of Prostasomes by a Combination of Dynamic Light Scattering and Proteomic Analysis
Davide Chiasserini, Michela Mazzoni, Federico Bordi, et al.
Frontiers in Oncology
|
November 23, 2020
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
Kelechi Njoku, Davide Chiasserini, Eleanor R Jones, et al.
Page
of 9